Fate Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.

CEO

J. Scott Wolchko

CEOJ. Scott Wolchko

Employees

449

Employees449

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

449

Employees449

FATE Key Statistics

Market cap

2.20B

Market cap2.20B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.19M

Average volume1.19M

High today

$23.14

High today$23.14

Low today

$22.04

Low today$22.04

Open price

$22.80

Open price$22.80

Volume

1.02M

Volume1.02M

52 Week high

$66.56

52 Week high$66.56

52 Week low

$17.10

52 Week low$17.10

Analyst ratings

79%

of 19 ratings

Buy

78.9%

Hold

21.1%

Sell

FATE Earnings

-$0.82

-$0.55

-$0.27

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, After Hours

ActualExpected Nov 3, After Hours